REIMBURSEMENT UNRAVELLED: One step at a time towards HTA and reimbursement goals in South Africa
This article was originally published in Clinica
To the outsider, progress in establishing public sector reimbursement and HTA systems in South Africa might seem slow – as are the plans for the national regulatory system. But a closer look reveals that HTA processes are becoming ingrained, and plans for national health insurance (NHI) are on the health ministry’s agenda. SAMED executive officer Tanya Vogt and local HTA expert Jani Müller provide an update on a healthcare system that is becoming increasingly evidence based
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.